A live webcast of the call will be available on the First Tracks website at: The data will be provided in a morning press release and presented during the webcast. A replay of the webcast will be ...

Acoramidis Associated with Significantly Improved Clinical Outcomes Versus Tafamidis in ATTR-CM in an Independent, Real-World Study of U.S. Electronic Health Records ...

In April 2026, AB Science announced that it had reached a final agreement with its financial creditors. This agreement provides for a two-year deferral of the repayment of the State-Guaranteed Loans ...

J-Star Holding Co., Ltd. is a global manufacturer of carbon fiber and composite material products, with a legacy in high-performance cycling components and a growing portfolio of applications across ...

AEON Biopharma is a biopharmaceutical company pursuing full-label access to the U.S. therapeutic neurotoxin market via biosimilarity to BOTOX ®. The U.S. therapeutic neurotoxin market exceeds $3.0 ...

"The issue is not the sugar itself so much as how long it stays on the teeth," said Dr. Northcott. "Sticky candy glues itself to the enamel. A child who eats gummy candies and runs off to play is ...

MESQUITE, Texas, Oct. 09, 2026 (GLOBE NEWSWIRE) -- National Breathe Free is proud to welcome Metro ENT and Geetha Subramanian, MD, to its network of physician-led ear, nose and throat practices.

Statistically significant improvement with ExoPTEN: ExoPTEN-treated eyes showed a statistically significant improvement in retinal response compared with injured eyes in the control group. This ...

J. Wood Capital Advisors acted as financial advisor to Vaxcyte in connection with the note offering.

HCW11-018b is Company’s lead candidate in its second-generation T-Cell Engager Program constructed using proprietary non-FC based TRBC platform technology MIRAMAR, Fla., Oct. 09, 2026 (GLOBE NEWSWIRE) ...

RadiusXR and Topcon Healthcare, Inc. unveil InspirePRO at AAO: the full measurement range expertly engineered into a lightweight wearable experience. NEW ORLEANS, Oct. 09, 2026 (GLOBE NEWSWIRE) -- ...

Dr. Kozauer and Mr. Miller each received an option to purchase 200,000 shares of LB Pharmaceuticals’ common stock. The options carry a ten-year term and an exercise price per share equal to $37.22, ...